Nexam Chemical Holding Future Growth

Future criteria checks 4/6

Nexam Chemical Holding se prevé un crecimiento anual de los beneficios y los ingresos de 104.7% y 15.4% respectivamente. Se prevé que el BPA sea de grow en 105.7% al año. Se prevé que la rentabilidad de los fondos propios sea de 5.3% en 3 años.

Key information

104.7%

Earnings growth rate

105.7%

EPS growth rate

Chemicals earnings growth	9.5%
Revenue growth rate	15.4%
Future return on equity	5.3%
Analyst coverage	Low
Last updated	31 Jan 2024

Recent future growth updates

Earnings Release: Here's Why Analysts Cut Their Nexam Chemical Holding AB (publ) (STO:NEXAM) Price Target To kr4.00

Feb 03

Recent updates

Earnings Release: Here's Why Analysts Cut Their Nexam Chemical Holding AB (publ) (STO:NEXAM) Price Target To kr4.00

Feb 03

Nexam Chemical Holding AB (publ)'s (STO:NEXAM) Subdued P/S Might Signal An Opportunity

Dec 07

Analysts Are Optimistic We'll See A Profit From Nexam Chemical Holding AB (publ) (STO:NEXAM)

Apr 20

Estimating The Fair Value Of Nexam Chemical Holding AB (publ) (STO:NEXAM)

Feb 28

What Kind Of Shareholders Hold The Majority In Nexam Chemical Holding AB (publ)'s (STO:NEXAM) Shares?

Feb 09

Nexam Chemical Holding's(STO:NEXAM) Share Price Is Down 17% Over The Past Five Years.

Jan 19

Nexam Chemical Holding AB (publ) (STO:NEXAM): Are Analysts Optimistic?

Dec 30

Is Nexam Chemical Holding (STO:NEXAM) A Risky Investment?

Dec 09

Earnings and Revenue Growth Forecasts

OM:NEXAM - Analysts future estimates and past financials data (SEK Millions)
Date	Revenue	Earnings	Free Cash Flow	Cash from Op	Avg. No. Analysts
12/31/2026	302	11	7	19	1
12/31/2025	257	4	3	13	1
12/31/2024	219	-4	9	18	1
12/31/2023	190	-23	-10	0	N/A
9/30/2023	195	-24	-33	0	N/A
6/30/2023	206	-23	-37	-10	N/A
3/31/2023	220	-15	-39	-6	N/A
12/31/2022	222	-13	-44	-11	N/A
9/30/2022	223	-10	2	8	N/A
6/30/2022	217	-9	1	14	N/A
3/31/2022	221	-7	3	9	N/A
12/31/2021	219	-5	1	7	N/A
9/30/2021	209	-7	-22	-15	N/A
6/30/2021	200	-6	-25	-15	N/A
3/31/2021	177	-8	-16	-9	N/A
12/31/2020	166	-8	-23	-17	N/A
9/30/2020	151	-11	-24	-18	N/A
6/30/2020	141	-14	-21	-10	N/A
3/31/2020	140	-13	-22	-11	N/A
12/31/2019	130	-17	-32	-21	N/A
9/30/2019	128	-15	-24	-17	N/A
6/30/2019	122	-17	-28	-22	N/A
3/31/2019	115	-17	-27	-22	N/A
12/31/2018	110	-17	-18	-13	N/A
9/30/2018	90	-4	-18	-13	N/A
6/30/2018	66	-2	-18	-14	N/A
3/31/2018	43	-5	-21	-17	N/A
12/31/2017	19	-6	-22	-18	N/A
9/30/2017	11	-21	N/A	-19	N/A
6/30/2017	10	-22	N/A	-19	N/A
3/31/2017	10	-22	N/A	-22	N/A
12/31/2016	8	-22	N/A	-18	N/A
9/30/2016	9	-19	N/A	-14	N/A
6/30/2016	12	-16	N/A	-16	N/A
3/31/2016	8	-16	N/A	-16	N/A
12/31/2015	8	-22	N/A	-23	N/A
9/30/2015	6	-29	N/A	-30	N/A
6/30/2015	2	-34	N/A	-34	N/A
3/31/2015	2	-38	N/A	-37	N/A
12/31/2014	2	-35	N/A	-31	N/A
9/30/2014	0	-33	N/A	-29	N/A
6/30/2014	1	-31	N/A	-27	N/A
3/31/2014	2	-28	N/A	-25	N/A
12/31/2013	3	-27	N/A	-25	N/A
9/30/2013	2	-23	N/A	-24	N/A
6/30/2013	2	-21	N/A	-20	N/A

Analyst Future Growth Forecasts

Ingresos vs. tasa de ahorro: NEXAM se prevé que sea rentable en los próximos 3 años, lo que se considera un crecimiento más rápido que la tasa de ahorro (0.9%).

Beneficios frente mercado: NEXAM se prevé que sea rentable en los próximos 3 años, lo que se considera un crecimiento del mercado superior a la media.

Beneficios de alto crecimiento: NEXAM se espera que sea rentable en los próximos 3 años.

Ingresos vs. Mercado: NEXAMSe prevé que los ingresos de la empresa (15.4% al año) crezcan más deprisa que los del mercado Swedish (1% al año).

Ingresos de alto crecimiento: NEXAMSe prevé que los ingresos de la empresa (15.4% al año) crezcan más despacio que 20% al año.

Earnings per Share Growth Forecasts

Future Return on Equity

Futura rentabilidad financiera (ROE): NEXAMSe prevé que la Rentabilidad de los fondos propios de la empresa sea baja dentro de 3 años (5.3%).

Discover growth companies

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Nexam Chemical Holding Future Growth

Future criteria checks 4/6

Key information

Recent future growth updates

Earnings Release: Here's Why Analysts Cut Their Nexam Chemical Holding AB (publ) (STO:NEXAM) Price Target To kr4.00

Forecast breakeven date moved forward to 2025

No longer forecast to breakeven

Forecast breakeven date pushed back to 2025

Consensus EPS estimates fall by 121%

Forecast breakeven date moved forward to 2024

Recent updates

Independent Director recently bought kr64k worth of stock

Jonna Opitz Has Declines Re-Election as the Board Member of Nexam Chemical Holding AB (Publ)

New minor risk - Share price stability

Chief Executive Officer recently bought kr153k worth of stock

Earnings Release: Here's Why Analysts Cut Their Nexam Chemical Holding AB (publ) (STO:NEXAM) Price Target To kr4.00

New minor risk - Financial position

Forecast breakeven date moved forward to 2025

New major risk - Revenue and earnings growth

Nexam Chemical Holding AB (publ)'s (STO:NEXAM) Subdued P/S Might Signal An Opportunity

Independent Director recently bought kr84k worth of stock

New minor risk - Financial position

Nexam Chemical Holding AB (publ) to Report Q1, 2024 Results on Apr 18, 2024

Third quarter 2023 earnings released: kr0.047 loss per share (vs kr0.029 loss in 3Q 2022)

No longer forecast to breakeven

Nexam Chemical Together with the Norwegian Company Aion, Developed A Recycled Plastic Material with the Right Colour and Properties

Nexam Chemical Holding AB (publ), Annual General Meeting, May 14, 2024

New minor risk - Profitability

Independent Chairman recently bought kr64k worth of stock

Independent Chairman recently bought kr102k worth of stock

Chief Executive Officer recently bought kr350k worth of stock

Forecast breakeven date pushed back to 2025

New minor risk - Share price stability

Second quarter 2023 earnings: EPS and revenues miss analyst expectations

Now 24% undervalued after recent price drop

Consensus EPS estimates fall by 121%

Estimating The Fair Value Of Nexam Chemical Holding AB (publ) (STO:NEXAM)

Nexam Chemical Holding (STO:NEXAM) Has Debt But No Earnings; Should You Worry?

Chief Executive Officer recently bought kr106k worth of stock

Less than half of directors are independent

Nexam Chemical Holding AB (publ) Approves Board Changes

Full year 2022 earnings: EPS and revenues miss analyst expectations

Nexam Chemical Receives Approval for the Use of Nexamite in Bottles and Food Packaging in Japan

Forecast breakeven date moved forward to 2024

Full year 2022 earnings: EPS and revenues miss analyst expectations

Nexam Chemical Holding AB (publ) to Report Fiscal Year 2023 Results on Jan 31, 2024

Price target decreased to kr15.00

Third quarter 2022 earnings: EPS misses analyst expectations

Nexam Chemical Holding AB (publ) to Report Q1, 2023 Results on Apr 20, 2023

Nexam Chemical Holding AB (publ), Annual General Meeting, May 09, 2023

Now 20% undervalued after recent price drop

Nexam Chemical Appoints Christer Svanberg as New Chief Technology Officer Replacing Francesco Pisciotti

Forecast breakeven date pushed back to 2023

Now 23% undervalued after recent price drop

Second quarter 2022 earnings: EPS and revenues miss analyst expectations

Price target increased to kr18.00

Nexam Chemical Appoints Borys Schafran as a New Business Development Consultant

Price target decreased to kr16.50

Now 25% undervalued after recent price drop

Chief Financial Officer recently bought kr135k worth of stock

Chief Executive Officer recently bought kr60k worth of stock

Chief Executive Officer recently bought kr135k worth of stock

First quarter 2022 earnings: EPS and revenues miss analyst expectations

First quarter 2022 earnings: EPS and revenues miss analyst expectations

Now 20% undervalued after recent price drop

Now 20% undervalued after recent price drop

Director recently bought kr70k worth of stock

Director recently bought kr70k worth of stock

Now 21% undervalued after recent price drop

Is Nexam Chemical Holding (STO:NEXAM) Using Debt In A Risky Way?

Independent Chairman of the Board recently bought kr171k worth of stock

Now 23% undervalued after recent price drop

Director recently bought kr376k worth of stock

Independent Chairman of the Board recently bought kr212k worth of stock

Price target decreased to kr16.50

Insider recently bought kr157k worth of stock

Chief Executive Officer recently bought kr306k worth of stock

Third quarter 2021 earnings released: kr0.027 loss per share (vs kr0.015 loss in 3Q 2020)

Second quarter 2021 earnings released: kr0.017 loss per share (vs kr0.047 loss in 2Q 2020)

Nexam Chemical Holding (STO:NEXAM) Has Debt But No Earnings; Should You Worry?